Skip to main contentSkip to navigation
Sirius Investors

CKMTF Stock: Carmat S.A. Stock Price, Analysis & Insights

Get live CKMTF stock price $12.75, comprehensive Carmat S.A. stock analysis, charts, news, and expert forecast. Real-time CKMTF stock data and investment insights.

12.75
50.96%Today
CKMTFCarmat S.A. • Other OTC • Healthcare
Market Cap
85.19M
Volume
448
52W High
12.75
52W Low
12.75

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Carmat S.A. is dedicated to engineering and producing cutting-edge total artificial hearts. These innovative devices are developed to aid patients afflicted with severe, end-stage biventricular heart failure, serving markets in France and across the ...

Company Information

CEO
Stephane Piat
Sector
Healthcare
Industry
Medical - Devices
Employees
182

Contact Information

Address
36, avenue de l'Europe
Country
FR

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Higher growth potential with elevated volatility (Beta: 1.38)

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Carmat S.A. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Carmat S.A.
  • Investors should consider how Carmat S.A. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

85.19M

P/E Ratio (TTM)

-3.32

Beta

1.38

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.